Clinical Trials to Treat Pituitary Tumors
Nivolumab and Ipilimumab in Treating Patients with Rare Tumors
This clinical trial studies nivolumab and ipilimumab in treating patients with rare tumors. Monoclonal antibodies, such as nivolumab and ipilimumab, may interfere with the ability of tumor cells to grow and spread.
Location: 780 locations
Proton Beam Radiation Therapy in Evaluating Local Control, Quality of Life, and Toxicities in Patients with Brain Tumors
This clinical trial studies the local control, quality of life, late toxicities in patients with brain tumors following proton beam radiation therapy. Proton beam radiation therapy uses high energy protons to kill tumor cells and shrink tumors. Evaluating local control and quality of life may help to define pre-irradiation versus post-irradiation functional changes in patients following proton beam radiation therapy.
Location: Massachusetts General Hospital, Charlestown, Massachusetts
Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in a Novartis-sponsored Study.
The purpose of this study is to allow continued use of pasireotide in patients who are on pasireotide treatment in a Novartis-sponsored, Oncology Clinical Development & Medical Affairs (CD&MA) study and are benefiting from the treatment as judged by the investigator.
Location: Memorial Sloan-Kettering Cancer Center, New York, New York
Mifepristone in Treating Patients With Cancer
The purpose of this compassionate use study is to see if mifepristone prevents worsening of patients' cancer. Mifepristone is an antiprogesterone agent, a drug which blocks female hormones, that is commonly used for the termination of pregnancies. Mifepristone has not been approved by the Food and Drug Administration for use in the treatment of cancer. However, previous work has indicated that mifepristone may be useful due to how it works.
Location: University of New Mexico Cancer Center, Albuquerque, New Mexico